Why the study?
Does general anesthesia with volatile anesthetics and succinylcholine cause complications in patients with cardiac ryanodine receptor (RyR2) defects?
Does general anesthesia with volatile anesthetics and succinylcholine cause complications in patients with cardiac ryanodine receptor (RyR2) defects?
Volatile anesthetics and succinylcholine appear safe for use in patients with cardiac RyR2 defects (CPVT), demonstrating an isoform-specific effect compared to the malignant hyperthermia risk seen in skeletal muscle RyR1 defects.
In Brief Familial polymorphic (catecholaminergic) ventricular tachycardia is an arrhythmogenic cardiac disorder caused by mutations of the myocardial isoform of the ryanodine receptor gene (RyR2). Mutations of the corresponding gene in the skeletal muscle (RyR1) predispose its carriers to malignant hyperthermia upon use of volatile anesthetics or succinylcholine, which further deteriorate the inherited intracellular calcium release disorder. We report a series of patients with cardiac RyR defects who underwent general anesthesia without complications. Succinylcholine and volatile anesthetics did not have a clinically significant effect on RyR2 defects. IMPLICATIONS: We report a series of patients with cardiac ryanodine receptor (RyR) defects who had general anesthesia. Succinylcholine and volatile anesthetics do not seem to have a clinically significant effect on cardiac RyR2. This suggests an isoform-specific effect of these compounds on the RyR1 calcium channel, the mutations of which are associated with malignant hyperthermia.
No takes yet. Share an insight, caveat, or question.
Swan et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: